Tempted to skip the floss? Your heart might thank you if you don't. A new study from Hiroshima University (HU) finds that the ...

New research shows that the gum disease bacterium P. gingivalis can slip into the bloodstream and infiltrate the heart. There, it quietly drives scar tissue buildup -- distorting the heart's ...

The role of ACE inhibitors in the management of HFPEF is less significant compared with their role in the management of heart failure ... edema, 1 hypotension, 3 increase in serum creatinine, 3 ...

In this single-arm trial, the median overall survival (OS) observed was 4.0 months (95% CI: 2.5-7.2) among all 64 adults in the primary efficacy analysis based on the Kaplan-Meier estimate. The median ...

It is usually removed during exhalation, but certain medical conditions such as chronic obstructive pulmonary disease (COPD), cystic fibrosis, and neuromuscular ... respiratory failure, seizure, and ...

Stanford Cardiovascular Institute researchers have discovered a mechanosensing-based approach that reduces cardiac fibrosis ...

Common symptoms of heart failure include feelings of tiredness and weakness, shortness of breath even during sleep, difficulty breathing while lying flat, and swelling in the legs, ankles and ...

Naim Alkhouri, MD, spoke to the potential for glucagon-like peptide-1 (GLP-1) receptor agonists to transform the treatment ...

A scientific statement regarding risk-based primary prevention of heart failure has been published by the American Heart Association.

Once-monthly efimosfermin alfa prescribed for metabolic dysfunction–associated steatohepatitis with F2 and F3 fibrosis ...

Eli Lilly's tirzepatide has been shown to significantly cut cardiovascular risks in patients with obesity and a form of heart failure with few treatment options, in another big win for the GLP-1 ...